Cargando…
The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
BACKGROUND: The Glasgow Prognostic Score (GPS) measures inflammation and proves its prognostic value in patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTL) which is commonly combined with inflammatory lesion. Given inflammatory chemokines play an important role in tumor progression,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437674/ https://www.ncbi.nlm.nih.gov/pubmed/25966773 http://dx.doi.org/10.1186/s13045-015-0142-4 |
_version_ | 1782372243489161216 |
---|---|
author | Kim, Seok Jin Ryu, Kyung Ju Hong, Mineui Ko, Young Hyeh Kim, Won Seog |
author_facet | Kim, Seok Jin Ryu, Kyung Ju Hong, Mineui Ko, Young Hyeh Kim, Won Seog |
author_sort | Kim, Seok Jin |
collection | PubMed |
description | BACKGROUND: The Glasgow Prognostic Score (GPS) measures inflammation and proves its prognostic value in patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTL) which is commonly combined with inflammatory lesion. Given inflammatory chemokines play an important role in tumor progression, we hypothesized that chemokines might influence ENKTL aggressiveness through interaction with their receptors in the tumor tissue. METHODS: We measured the serum levels of C-X-C motif ligand 13 (CXCL13) in 69 patients with ENKTL who received non-anthracycline-based chemotherapy and/or concurrent chemoradiotherapy because CXCL13 is thought to have a pro-tumor effect through interaction with its receptor, the C-X-C chemokine receptor 5 (CXCR5). We analyzed the association of serum CXCL13 with the GPS, and their prognostic relevance. The levels of CXCL13 were measured using a multiplex chemokine assay on archived frozen serum samples. RESULTS: Patients were categorized into high and low CXCL13 groups if they had CXCL13 levels above or below the median value of 29.1 pg/mL, respectively. The high CXCL13 group and grouping by the GPS showed a significant association with poor progression-free survival. The elevated serum levels of CXCL13 were also significantly associated with a high score of the GPS. High CXCL13 levels and GPS were significantly associated with high tumor burden predicting poor prognosis including stages III/IV, extranasal presentation, bone marrow invasion, and presence of Epstein-Barr virus (EBV) DNA in blood. Furthermore, serum CXCL13 and GPS discriminated patients at risk of treatment failure among patients with low tumor burden (stage I/II) and non-detectable EBV DNA. CONCLUSIONS: Serum levels of CXCL13 were associated with the prognostic value of GPS. Grouping by the serum CXCL13 might predict survival outcomes in patients with ENKTL, suggesting that it is a potential therapeutic target. |
format | Online Article Text |
id | pubmed-4437674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44376742015-05-20 The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients Kim, Seok Jin Ryu, Kyung Ju Hong, Mineui Ko, Young Hyeh Kim, Won Seog J Hematol Oncol Rapid Communication BACKGROUND: The Glasgow Prognostic Score (GPS) measures inflammation and proves its prognostic value in patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTL) which is commonly combined with inflammatory lesion. Given inflammatory chemokines play an important role in tumor progression, we hypothesized that chemokines might influence ENKTL aggressiveness through interaction with their receptors in the tumor tissue. METHODS: We measured the serum levels of C-X-C motif ligand 13 (CXCL13) in 69 patients with ENKTL who received non-anthracycline-based chemotherapy and/or concurrent chemoradiotherapy because CXCL13 is thought to have a pro-tumor effect through interaction with its receptor, the C-X-C chemokine receptor 5 (CXCR5). We analyzed the association of serum CXCL13 with the GPS, and their prognostic relevance. The levels of CXCL13 were measured using a multiplex chemokine assay on archived frozen serum samples. RESULTS: Patients were categorized into high and low CXCL13 groups if they had CXCL13 levels above or below the median value of 29.1 pg/mL, respectively. The high CXCL13 group and grouping by the GPS showed a significant association with poor progression-free survival. The elevated serum levels of CXCL13 were also significantly associated with a high score of the GPS. High CXCL13 levels and GPS were significantly associated with high tumor burden predicting poor prognosis including stages III/IV, extranasal presentation, bone marrow invasion, and presence of Epstein-Barr virus (EBV) DNA in blood. Furthermore, serum CXCL13 and GPS discriminated patients at risk of treatment failure among patients with low tumor burden (stage I/II) and non-detectable EBV DNA. CONCLUSIONS: Serum levels of CXCL13 were associated with the prognostic value of GPS. Grouping by the serum CXCL13 might predict survival outcomes in patients with ENKTL, suggesting that it is a potential therapeutic target. BioMed Central 2015-05-14 /pmc/articles/PMC4437674/ /pubmed/25966773 http://dx.doi.org/10.1186/s13045-015-0142-4 Text en © Kim et al. ; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Rapid Communication Kim, Seok Jin Ryu, Kyung Ju Hong, Mineui Ko, Young Hyeh Kim, Won Seog The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients |
title | The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients |
title_full | The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients |
title_fullStr | The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients |
title_full_unstemmed | The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients |
title_short | The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients |
title_sort | serum cxcl13 level is associated with the glasgow prognostic score in extranodal nk/t-cell lymphoma patients |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437674/ https://www.ncbi.nlm.nih.gov/pubmed/25966773 http://dx.doi.org/10.1186/s13045-015-0142-4 |
work_keys_str_mv | AT kimseokjin theserumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT ryukyungju theserumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT hongmineui theserumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT koyounghyeh theserumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT kimwonseog theserumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT kimseokjin serumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT ryukyungju serumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT hongmineui serumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT koyounghyeh serumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients AT kimwonseog serumcxcl13levelisassociatedwiththeglasgowprognosticscoreinextranodalnktcelllymphomapatients |